Clinical Trials

Blogs

New COVID-19 Testing Technology + FDA Approves First Drug for HER2-Low Breast Cancer – Xtalks Life Science Podcast Ep. 72
Blogs

Expanded Approval for Gout Drug + Novavax COVID-19 Vaccine Gets FDA Authorization – Xtalks Life Science Podcast Ep. 69

Cultural-Linguistic Considerations for Successful Cognitive Endpoint Assessment in International CNS Clinical Trials

June 16, 2022

Maximize Value with 2-Way Integrations in Clinical Trial Management

May 12, 2022

Advancing Data Management and Monitoring – Change the Game With Integrated eSource/EMR/EDC

May 18, 2022

How to Avoid Significant Delays in Multi-country Studies Due to EU 536/2014 Clinical Trial Regulation

January 27, 2022

NASH Populations with Cirrhosis: Drug Development Challenges and Solutions

February 16, 2022

Establishing an Expert Network for Your Radiopharmaceutical Drug Development Program

November 05, 2021
Blogs

How the Approval of Aducanumab Will Change Alzheimer’s Trials — Xtalks Life Science Podcast Ep. 25
Blogs

AAIC 2021: Six Ways the Approval of Aducanumab Will Change Alzheimer’s Clinical Trials
Blogs

AAIC 2021: Best Practices for Remote Cognitive Assessments for Alzheimer’s Patients During COVID-19

AI and Cloud – Power of Modern Trial Infrastructure for Accelerated Drug Development

May 21, 2021

Cardiovascular event adjudication during COVID-19 and Beyond

May 21, 2021
Blogs

Clinical Research Jobs: How to Choose the Right Career Path
Blogs

Why Every Organization Needs a Clinical Data Strategy
Blogs

New White Paper on Advanced Therapies Sets up Developers for Success